| Filed On | Filing |
|---|---|
| 06 Feb 2025 |
Form 4/A: Goldenberg Gary, Chief Medical Officer
Received 50,000 shares as a grant or award |
| 06 Feb 2025 |
Form 4/A: Kohler Terry, CHIEF FINANCIAL OFFICER
Received 125,000 shares as a grant or award |
| 06 Feb 2025 |
Form 4/A: Hayes Christopher G., CHIEF LEGAL OFFICER
Received 150,000 shares as a grant or award |
| 06 Feb 2025 |
Form 4/A: White Ted, Director
Received 150,000 shares as a grant or award |
| 06 Feb 2025 |
Form 4/A: Bonaccorso Joe, CHIEF COMMERCIAL OFFICER
Received 125,000 shares as a grant or award |
| 21 Feb 2023 |
Form 4/A: White Ted, Director
Bought 7,500 shares ($15.8K) |
| 17 Jun 2021 |
Form 4/A: Prygocki Mark A Sr, Director
Granted 8,109 Stock Option (right to buy) |
| 17 Jun 2021 |
Form 4/A: Nguyen Diem, Director
Granted 8,109 Stock Option (right to buy) |
| 17 Jun 2021 |
Form 4/A: Ballaron Craig, Director
Granted 8,109 Stock Option (right to buy) |
| 17 Jun 2021 |
Form 4/A: Eichenfield Lawrence, Director
Granted 8,109 Stock Option (right to buy) |
Loading...